ICT-140

N/A

Report date: 2025/01/08 11:53:10

Base Information

Drug NameICT-140

Drug Alias NameICT-140

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccineVaccines > Vaccine type > Multivalent vaccine

Mechanisms of ActionImmunostimulantsAnti-IL13RA2Anti-HER2 +[4]

TargetsInterleukin-13 receptor subunit alpha-2Receptor protein-tyrosine kinase erbB-2Mesothelin

Therapy Area/IndicationsOvarian Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesImmunocellular Therapeutics Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesImmunocellular Therapeutics Ltd

Active IndicationsN/A

Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A